265 related articles for article (PubMed ID: 9355787)
1. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE).
Ferraris R; Bonelli L; Conio M; Fracchia M; Lapertosa G; Aste H
Eur J Gastroenterol Hepatol; 1997 Sep; 9(9):881-5. PubMed ID: 9355787
[TBL] [Abstract][Full Text] [Related]
2. Barrett's esophagus: epidemiological and clinical results of a multicentric survey. Gruppo Operativo per lo Studio delle Precancerosi dell'Esofago (GOSPE).
Int J Cancer; 1991 May; 48(3):364-8. PubMed ID: 2040529
[TBL] [Abstract][Full Text] [Related]
3. Barrett's esophagus: results of a multicentric survey. G.O.S.P.E. (Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
Bonelli L
Endoscopy; 1993 Nov; 25(9):652-4. PubMed ID: 8119225
[No Abstract] [Full Text] [Related]
4. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis.
Caygill CP; Reed PI; Johnston BJ; Hill MJ; Ali MH; Levi S
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1355-8. PubMed ID: 10654794
[TBL] [Abstract][Full Text] [Related]
5. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
6. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
Rana PS; Johnston DA
Dis Esophagus; 2000; 13(1):28-31. PubMed ID: 11005328
[TBL] [Abstract][Full Text] [Related]
7. Barrett's oesophagus: epidemiology, diagnosis and clinical management.
Whiteman DC; Kendall BJ
Med J Aust; 2016 Oct; 205(7):317-24. PubMed ID: 27681974
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for Barrett's oesophagus: results from a programme in Northern Ireland.
Murphy SJ; Dickey W; Hughes D; O'Connor FA
Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1029-35. PubMed ID: 16148547
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
[TBL] [Abstract][Full Text] [Related]
10. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic features of Barrett's esophagus. G.O.S.P.E. Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
Conio M
Endoscopy; 1993 Nov; 25(9):642-4. PubMed ID: 8119222
[No Abstract] [Full Text] [Related]
12. Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma.
Hurschler D; Borovicka J; Neuweiler J; Oehlschlegel C; Sagmeister M; Meyenberger C; Schmid U
Swiss Med Wkly; 2003 Sep; 133(37-38):507-14. PubMed ID: 14652799
[TBL] [Abstract][Full Text] [Related]
13. A surveillance programme for Barrett's oesophagus in a UK general hospital.
Olithselvan A; Gorard DA; McIntyre AS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
[TBL] [Abstract][Full Text] [Related]
14. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori in Barrett's oesophagus. Gruppo Operativo per lo Studio Delle Precancerosi Esofagee (GOSPE)--Precancerous Lesions of the Oesophagus Task Force, Italy.
Histopathology; 1991 Jun; 18(6):568-70. PubMed ID: 1879820
[No Abstract] [Full Text] [Related]
16. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
18. Audit of a Barrett's epithelium surveillance database.
Basu KK; Pick B; de Caestecker JS
Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):171-5. PubMed ID: 15075990
[TBL] [Abstract][Full Text] [Related]
19. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
[TBL] [Abstract][Full Text] [Related]
20. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
Drewitz DJ; Sampliner RE; Garewal HS
Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
